-- 紐西蘭統計局週二公佈的數據顯示,紐西蘭3月季度的年度消費者通膨率上漲了3.1%。 據Trading Economics稱,該季度的年度通膨率超過了先前2.9%的普遍預期。西太平洋銀行新西蘭高級經濟學家薩蒂什·蘭喬德(Satish Ranchhod)也預測了2.8%的漲幅。 該部門表示,這一數字與截至2025年12月季度的12個月的3.1%的漲幅持平。 西太平洋銀行紐西蘭的蘭喬德表示,這項結果也超過了紐西蘭儲備銀行(RBNZ)在4月份政策更新中更新的3%的年度通膨預期。 這些數據也印證了紐西蘭儲備銀行行長安娜·布雷曼(Anna Breman)在3月份的一次演講中提出的更高的整體通膨預期。 紐西蘭統計局價格與平減指數發言人尼古拉·格羅登(Nicola Growden)表示,電力價格飆升了12.5%,相當於通膨率上漲幅度的10%以上。 據格羅登稱,電力價格連續第三個季度成為年度通膨的最大推手。 地方政府稅費在3月季度上漲了8.8%,對通膨的貢獻率為8.7%。 肉類和家禽價格在該季度上漲了8.6%,對年度通膨的貢獻率為6.4%。 紐西蘭統計局表示,租金上漲了1.2%,佔總通膨漲幅的4.6%;汽油價格小幅上漲了1.1%,對通膨的貢獻率為1.3%。 該部門的數據顯示,2026年3月季度的季度通膨率較2025年12月季度上漲了0.9%。 格羅登在一份聲明中表示:“汽油是新西蘭家庭繼租金和建築成本之後的第三大支出項目。” 根據紐西蘭統計局的數據,汽油價格佔典型家庭支出的3.5%。該數據基於2024年消費者物價指數(CPI)的重新加權,該指數採用了家庭支出數據。 紐西蘭統計局的報告指出,由於處方藥費用上漲,藥品價格在本季上漲了17.7%。 展望未來,西太平洋銀行和紐西蘭儲備銀行預計,通膨率將在6月達到4.3%的峰值,然後在年底回落至3.9%。 蘭喬德在他的分析中表示:“今天的結果表明,這些預測存在上行風險。” 蘭喬德也指出,6月的油價以及相關的運輸和其他成本可能會對通膨數據構成壓力。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.